AI assistant
Werewolf Therapeutics, Inc. — Director's Dealing 2021
Apr 29, 2021
34192_dirs_2021-04-29_94a56eaf-2b22-416c-8c19-0e7ce5939b6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Werewolf Therapeutics, Inc. (HOWL)
CIK: 0001785530
Period of Report: 2021-04-29
Reporting Person: Longwood Fund III GP, LLC (10% Owner)
Reporting Person: Longwood Fund III, L.P. (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Preferred Stock | $ | Common Stock (1071127) | Indirect | ||
| Series B Preferred Stock | $ | Common Stock (355955) | Indirect |
Footnotes
F1: The Series A Preferred Stock is convertible into common stock on a 8.6691-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or automatically upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
F2: These securities are held of record by Longwood Fund III, L.P. ("Longwood III"). Longwood Fund III GP, LLC ("Longwood III GP") is the general partner of Longwood III. Voting, investment and dispositive decisions at Longwood III GP with respect to the securities held by Longwood III are made by an investment committee comprised of Christoph Westphal, Richard Aldrich and John Lawrence (collectively, the "IC Members"). Longwood III GP and each of the IC Members may be deemed to share voting, investment and dispositive power over the securities held by Longwood III and as a result may be deemed to have beneficial ownership over such securities. Longwood III GP and each of the IC Members disclaims beneficial ownership over the securities held by Longwood III, except to the extent of their respective pecuniary interests therein.
F3: The Series B Preferred Stock is convertible into common stock on a 8.6691-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or automatically upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.